Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States

Original Research | By Kwok CS, Bell M, Mamas MA et al.

Percutaneous Coronary Intervention Readmissions Where Are the Solutions?

Editorial | By Kalra A, Shishehbor MH, Simon DI.

Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients

Original Research | By Minges KE, Herrin J, Fiorilli PN et al.

Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Letter | By Yaylali YT, Basarici I.

Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Letter | By Zhang H, Chen SL.

Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension

Letter | By Chen L, Wang N, Peng B et al.

Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?

Expert Opinion | By Dimopoulos K, Ernst S, McCabe C et al.

Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial

Original Research | By Fox KAA, Eikelboom JW, Yusuf S et al.

Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice : An NCDR Registry to Practice Project

Original Research | By Katherine Hsin-Yu Chau, MD1,2; Kevin F. Kennedy, ; John C. Messenger, MD4; et al

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device?

Editorial | By King SB 3rd, Gogas BD.